• bit.bio has undertaken a COVID-19 risk assessment and we are COVID secure
  • info@bit.bio
  • +44 (0) 1223 787 297
Bit Bio
    • technology
    • about
      • who we are
      • team
      • spotlights
      • careers
      • sustainability
      • partner with us
    • ioCells
      • ioWild Type Cells
        • ioGlutamatergic Neurons
        • ioSkeletal Myocytes
        • ioGABAergic Neurons
      • ioDisease Model
        • ioGlutamatergic Neurons HTT 50CAG/WT
    • resources
      • bits of bio
      • blog
      • journals
      • posters
      • tutorial videos
      • videos
      • webinars
    • news
    • events
    • contact
    • technology
    • about
      • who we are
      • team
      • spotlights
      • careers
      • sustainability
      • partner with us
    • ioCells
      • ioWild Type Cells
        • ioGlutamatergic Neurons
        • ioSkeletal Myocytes
        • ioGABAergic Neurons
      • ioDisease Model
        • ioGlutamatergic Neurons HTT 50CAG/WT
    • resources
      • bits of bio
      • blog
      • journals
      • posters
      • tutorial videos
      • videos
      • webinars
    • news
    • events
    • contact

    News

    Article | When human stem cells take the shortcut

    Article | When human stem cells take the shortcut

    Jul 21, 2021

    Published by Kurier

    read more
    Article | £200m+ invested in Babraham Campus companies, what lies ahead?

    Article | £200m+ invested in Babraham Campus companies, what lies ahead?

    Jul 19, 2021

    Published by Business Weekly

    read more
    Review | UN Political Forum: Prioritising Post-Pandemic Law & Governance

    Review | UN Political Forum: Prioritising Post-Pandemic Law & Governance

    Jul 15, 2021

    Published by bit.bio

    read more
    Article | Rethinking biology coding cells for health | Davide Danovi bit.bio Head of Cellular Phenotyping

    Article | Rethinking biology coding cells for health | Davide Danovi bit.bio Head of Cellular Phenotyping

    Jun 29, 2021

    Published by Sci Foo

    read more
    Podcast | Founder and CEO Dr Mark Kotter discusses the uses of reprogrammed human cells in research and drug development

    Podcast | Founder and CEO Dr Mark Kotter discusses the uses of reprogrammed human cells in research and drug development

    Jun 29, 2021

    Published by Bioinformatics 

    read more
    Article | How the body's building blocks will revolutionise medicine

    Article | How the body's building blocks will revolutionise medicine

    Jun 29, 2021

    Published by MoneyWeek

    read more
    Podcast | The story of bit.bio on the Healthtech Podcast

    Podcast | The story of bit.bio on the Healthtech Podcast

    Jun 10, 2021

    Published by Healthtech podcast

    read more
    Article | CEO and founder Mark Kotter on Spectator TV about cultured meat

    Article | CEO and founder Mark Kotter on Spectator TV about cultured meat

    Jun 3, 2021

    Published by Spectator TV

    read more
    Article | bit.bio cell revolution looks to transform dementia treatments & grow organs

    Article | bit.bio cell revolution looks to transform dementia treatments & grow organs

    May 20, 2021

    Published by Daily Express

    read more
    Page 5 of 9 « 3 4 5 6 7 »

    Navigation

    • technology
    • about
    • careers
    • partner with us
    • resources
    • news
    • events
    • contact

    Products

    • ioGlutamatergic Neurons
    • ioSkeletal Myocytes
    • ioGABAergic Neurons
    • ioGlutamatergic Neurons HTT

    Subscribe to our newsletter

    ×

    Subscribe to our newsletter

    bit.bio © 2022 | All rights reserved | privacy policy | terms & conditions

    bit.bio © 2021 | All rights reserved
    privacy policy | terms & conditions